L. A. Baldrige

Basal cell carcinoma of the prostate is an aggressive tumor with frequent loss of PTEN expression and overexpression of EGFR.

Liang Cheng, Rodolfo Montironi, D. Grignon, 2015, Human pathology.

TMPRSS2‐ERG gene fusion is rare compared to PTEN deletions in stage T1a prostate cancer

Liang Cheng, Rodolfo Montironi, A. Lopez‐Beltran, 2016, Molecular carcinogenesis.

Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation

Kristin M. Post, D. Grignon, E. Compérat, 2016, Oncotarget.

Solitary fibrous tumour of the genitourinary tract: a clinicopathological study of 11 cases and their association with the NAB2-STAT6 fusion gene

D. Grignon, A. Lopez‐Beltran, R. Montironi, 2016, Journal of Clinical Pathology.

Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma

D. Grignon, E. Compérat, R. Montironi, 2015, Modern Pathology.

Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity

A. Sangoi, D. Grignon, R. Montironi, 2022, Modern Pathology.

Evaluating Mismatch Repair Deficiency for Solid Tumor Immunotherapy Eligibility: Immunohistochemistry versus Microsatellite Molecular Testing.

Liang Cheng, C. Luchini, Mingsheng Wang, 2021, Human pathology.

Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation

Kristin M. Post, D. Grignon, E. Compérat, 2016, OncoTarget.